Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04467515
Title A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Camel-IDS NV
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Stanford University Medical Center Stanford California 94305 United States Details
Georgetown University Medical Center Washington District of Columbia 20057 United States Details
Loyola University Medical Center Maywood Illinois 60153 United States Details
University of Iowa Iowa City Iowa 52242 United States Details
Johns Hopkins Hospital Baltimore Maryland 21287 United States Details
Advanced Molecular Imaging & Therapy Glen Burnie Maryland 21061 United States Details
Washington University School of Medicine in St. Louis Saint Louis Missouri 63110 United States Details
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
Princess Margaret Hospital Toronto Ontario Canada Details
Hospital Notre Dame du CHUM Montréal Quebec Canada Details
McGill University Faculty of Medicine - Royal Victoria Hospital Montréal Quebec Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field